Updated: Mar 10, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Liyan Zhuang1, Matthew T Johnson2
1Department of Urology, Lahey Hospital and Medical Center, Tufts University School of Medicine, Burlington, MA, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Precision medicine advances prostate cancer care. Genetic tests refine screening, rebiopsy decisions, and risk stratification, guiding treatment for better patient outcomes.
Area of Science:
Background:
Conclusions: